Business Context and Reporting Period
Company: EyePoint, Inc. (EYPT)
Filing Type: Form 8-K (Current Report)
Date of Report: March 20, 2026
Reporting Period: Event-based report regarding legal action initiated on March 20, 2026.
Key Financial Metrics
This filing is a legal disclosure under Item 7.01 (Regulation FD Disclosure) and does not contain financial statements. The filing text does not provide clear values for revenue, profit, cash flow, margins, debt, or liquidity.
Material Changes
The material change reported is the initiation of legal proceedings. On March 20, 2026, EyePoint, Inc. filed a complaint against Ocular Therapeutix, Inc. in the Middlesex County Superior Court for the Commonwealth of Massachusetts.
Guidance, Outlook, and Risks
- Legal Action: The Company alleges that Ocular Therapeutix, Inc. disseminated false or misleading representations concerning EyePoint and the clinical results of its lead product candidate, DURAVYU (vorolanib intravitreal insert).
- Causes of Action: The complaint asserts claims for defamation, commercial disparagement, violation of Mass. Gen. L. c. 93A, and tortious interference with advantageous business relations.
- Relief Sought: EyePoint is seeking injunctive relief to stop further dissemination of the alleged false statements, a public retraction, monetary damages, and attorneys' fees and costs.
- Forward-Looking Statements: The filing does not provide updated financial guidance or operational outlook beyond the context of this litigation.
Investor Verification Checklist
- Verify the specific nature of the "false or misleading representations" alleged against Ocular Therapeutix, Inc.
- Monitor the status of the lawsuit in the Middlesex County Superior Court for potential impacts on the DURAVYU product candidate.
- Assess the potential financial impact of legal fees and any potential damages sought.
- Review any public statements made by Ocular Therapeutix, Inc. in response to the complaint.